angiotensin ii has been researched along with fingolimod hydrochloride in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KO; Bang, BK; Choi, BS; Kim, J; Kim, JS; Kim, JY; Kim, YS; Li, C; Lim, SW; Yang, CW; Yang, HJ | 1 |
| Cartwright, EJ; Gui, J; Jin, J; Ke, Y; Lei, M; Liu, W; Naumann, R; Neyses, L; Prehar, S; Solaro, RJ; Taglieri, DM; Tsui, H; Ulm, S; Wang, X; Xiao, RP; Zi, M | 1 |
| Jiménez-Altayó, F; Jurado, A; Meissner, A; Miro, F; Planas, AM; Vila, E | 1 |
| Chen, C; Han, Q; Liang, W; Luo, Z; Lv, X; Su, K; Wang, Y; Yan, M; Zeng, P | 1 |
| Chen, T; Fan, X; He, S; Huang, CL; Jiang, F; Jiang, Q; Lei, M; Li, T; Ou, X; Tan, X; Yang, B; Zeng, X | 1 |
5 other study(ies) available for angiotensin ii and fingolimod hydrochloride
| Article | Year |
|---|---|
Effect of FTY720 on chronic cyclosporine nephropathy in rats.
Topics: Angiotensin II; Animals; Chronic Disease; Cyclosporine; Extracellular Matrix Proteins; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Kidney; Kidney Diseases; Lymphocytes; Macrophages; Male; Osteopontin; Propylene Glycols; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Sphingosine; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Female; Fingolimod Hydrochloride; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; p21-Activated Kinases; Propylene Glycols; Rats; Signal Transduction; Sphingosine; Stress, Physiological | 2011 |
Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.
Topics: Adoptive Transfer; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Transplantation; Cell Movement; Disease Models, Animal; Fingolimod Hydrochloride; Genetic Predisposition to Disease; Hypertension; Inflammation Mediators; Lymph Nodes; Lysophospholipids; Mesenteric Arteries; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; T-Lymphocytes; Time Factors; Vascular Remodeling | 2017 |
FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines.
Topics: Adult; Angiotensin II; Animals; Cell Adhesion; Enzyme-Linked Immunosorbent Assay; Female; Fingolimod Hydrochloride; Humans; Immunohistochemistry; Interleukin-6; Lysophospholipids; Male; Middle Aged; Podocytes; Radioimmunoassay; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Renal Insufficiency, Chronic; Sphingosine; Tumor Necrosis Factor-alpha; Wound Healing; Young Adult | 2017 |
Ventricular SK2 upregulation following angiotensin II challenge: Modulation by p21-activated kinase-1.
Topics: Angiotensin II; Animals; Apamin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Fingolimod Hydrochloride; Mice; Myocytes, Cardiac; p21-Activated Kinases; Protein Serine-Threonine Kinases; Rats; RNA, Small Interfering; Up-Regulation | 2022 |